Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 28, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed how Alzheimer disease research may change if aducanumab becomes approved.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Rajesh Pahwa, MD, on the challenges of medication adherence in Parkinson disease.
Multiple abstracts at SLEEP 2020 show CBT-I’s success in aiding women with insomnia, including women who are pregnant and female veterans both with and without PTSD.
Efforts to cut through regulatory red tape will help ensure earlier access to potentially lifesaving treatments for patients with spinal muscular atrophy.
Ravi Dukkipati, MD, discusses the data released at the AAN 2020 Annual Meeting regarding the use of ofatumumab in managing relapsing multiple sclerosis.